TRIM9-mediated anti-viral immune pathway
TRIM9介导的抗病毒免疫途径
基本信息
- 批准号:8857804
- 负责人:
- 金额:$ 41.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-02-05 至 2020-01-31
- 项目状态:已结题
- 来源:
- 关键词:Anti-Inflammatory AgentsAnti-inflammatoryAntiviral AgentsAntiviral ResponseBindingBiological AssayBone Marrow CellsBrainCUL1 geneComplexDefense MechanismsEarly DiagnosisEnsureEquilibriumF Box DomainF-Box ProteinsFigs - dietaryGene ExpressionGenesHarvestHistologicHomeostasisIRF3 geneImmuneImmune responseImmunityInflammationInflammatoryInflammatory ResponseInfluenza A virusInterferon Type IInterferonsInvadedLeadMeasurementMeasuresMediatingMolecularMusMutagenesisNeuronsNuclearPathway interactionsPatternPattern recognition receptorPeptidesPhasePhosphorylationProductionProtein FamilyProtein MicrochipsProteinsReceptor SignalingRecruitment ActivityRegulationRoleShapesSignal PathwaySignal TransductionSignaling MoleculeSplenocyteStagingTBK1 geneTRIM MotifTestingTetracyclinesTissuesTransducinTransgenic MiceUbiquitinationViralVirusVirus DiseasesWD RepeatWest Nile virusYin-Yangbasebeta-Transducin Repeat-Containing Proteinsbiodefensecytokinein vivoinhibitor/antagonistmetermouse modelnovelpathogenpreventprotein protein interactionpublic health relevanceresponsescaffoldscreeningtranscription factorubiquitin-protein ligase
项目摘要
DESCRIPTION (provided by applicant): The interferon regulatory factors IRF3 and IRF7 are the master transcription factors to sequentially induce the early and late phase of IFN-stimulated genes (ISG) upon TBK1-mediated phosphorylation, which limits viral replication through multiple mechanisms. In addition, the NF-B transcription factor is a critical regulator of the pathogen-induced proinflammatory response and its activity is primarily regulated by the SCF-βTrCP [SKP1-CUL1-F-box-βTrCP (β-transducin repeat-containing protein)] E3 ligase complex-mediated ubiquitination and degradation. Various intracellular restriction factors, including the tripartite motif (TRIM) protein family, cooperate with TBK1, IRF3/7, and NF-B transcription factors to develop effective anti-viral immune responses. From our functional screening of 75 TRIM proteins, we have identified a novel TRIM9 E3 ligase as a major innate yin-yang effector to develop balanced immune responses against viral infection. TRIM9 is primarily expressed in the brain, but its expression is rapidly induced in various other tissues upon viral infection. Our
study discovered that TRIM9 interacts with TBK1 and IRF3/7, leading to the robust activation of the type I IFN pathway. On the other hand, TRIM9 binds the WD repeat-containing F-box protein βTrCP of SCF E3 ligase complex in a phosphorylation dependent manner, resulting in the marked suppression of NF-B pathway. Based on these results, we hypothesize that TRIM9 shapes innate immune homeostasis by integrating positive and negative regulation of type I IFN anti-viral and NF-B proinflammatory responses, respectively: as a novel anti-viral factor, the TRIM9 E3 ligase differentially regulates type I IFN and NF-B signaling pathways in a genetically and functionally separable manner, developing well-balanced immune responses against viral infection.
描述(由申请人提供):干扰素调节因子IRF 3和IRF 7是主转录因子,在TBK 1介导的磷酸化后依次诱导IFN刺激基因(ISG)的早期和晚期,这通过多种机制限制病毒复制。此外,NF-κ B B转录因子是病原体诱导的促炎反应的关键调节因子,其活性主要由SCF-βTrCP [SKP 1-CUL 1-F-box-βTrCP(β-transducin repeat-containing protein)] E3连接酶复合物介导的泛素化和降解调节。各种细胞内限制因子,包括三重基序(TRIM)蛋白家族,与TBK 1、IRF 3/7和NF-κ B B转录因子合作以产生有效的抗病毒免疫应答。从我们对75种TRIM蛋白的功能筛选中,我们已经鉴定出一种新型TRIM 9 E3连接酶作为主要的先天阴阳效应子,以产生针对病毒感染的平衡免疫应答。TRIM 9主要在脑中表达,但在病毒感染后,其表达在各种其他组织中被迅速诱导。我们
研究发现TRIM 9与TBK 1和IRF 3/7相互作用,导致I型IFN途径的强烈激活。另一方面,TRIM 9以磷酸化依赖的方式结合SCF E3连接酶复合物的含有WD重复序列的F-box蛋白βTrCP,导致NF-κ B B途径的显著抑制。基于这些结果,我们假设TRIM 9通过整合I型IFN抗病毒和NF-κ B B促炎应答的正向和负向调节分别形成先天免疫稳态:作为一种新的抗病毒因子,TRIM 9 E3连接酶以遗传和功能上可分离的方式差异调节I型IFN和NF-κ B B信号传导途径,产生针对病毒感染的良好平衡的免疫应答。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jae U Jung其他文献
Signaling Role of Viral Protein Motif and Its Application in CAR T Cell Therapy
- DOI:
10.1182/blood-2023-186305 - 发表时间:
2023-11-02 - 期刊:
- 影响因子:
- 作者:
Kunho Chung;Wooram Jung;Jae U Jung;J. Joseph Melenhorst - 通讯作者:
J. Joseph Melenhorst
Jae U Jung的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jae U Jung', 18)}}的其他基金
Infant Immunologic and Neurologic Development following Maternal Infection in Pregnancy during Recent Epidemics
近期流行病期间妊娠期感染后婴儿的免疫和神经系统发育
- 批准号:
10784250 - 财政年份:2023
- 资助金额:
$ 41.2万 - 项目类别:
Reassortment of Bunyavirus in ticks and animal models
蜱和动物模型中布尼亚病毒的重排
- 批准号:
10512873 - 财政年份:2022
- 资助金额:
$ 41.2万 - 项目类别:
Reassortment of Bunyavirus in ticks and animal models
蜱和动物模型中布尼亚病毒的重排
- 批准号:
10686796 - 财政年份:2022
- 资助金额:
$ 41.2万 - 项目类别:
Structural analysis and therapeutic nanobody development of KSHV G-protein coupled receptor
KSHV G 蛋白偶联受体的结构分析和治疗性纳米抗体开发
- 批准号:
10413218 - 财政年份:2020
- 资助金额:
$ 41.2万 - 项目类别:
相似海外基金
Development of Enhanced Anti-inflammatory Blood Mononuclear Cell Therapy for ARDS and Elucidation of the Molecular Mechanism
ARDS增强抗炎血液单核细胞治疗的进展及分子机制的阐明
- 批准号:
23K07659 - 财政年份:2023
- 资助金额:
$ 41.2万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Exploring therapeutic effects of anti-inflammatory and resolving factors in osteoporosis model mice
探讨抗炎和缓解因子对骨质疏松模型小鼠的治疗作用
- 批准号:
23K15705 - 财政年份:2023
- 资助金额:
$ 41.2万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Investigation of the relation between age-related estradiol fluctuation and pro-/anti-inflammatory effects in transplant immune response.
研究年龄相关雌二醇波动与移植免疫反应中促/抗炎作用之间的关系。
- 批准号:
23K19490 - 财政年份:2023
- 资助金额:
$ 41.2万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Non-coating anti-microbial, anti-host protein deposition, anti-inflammatory urinary catheter
无涂层抗菌、抗宿主蛋白沉积、抗炎导尿管
- 批准号:
10697567 - 财政年份:2023
- 资助金额:
$ 41.2万 - 项目类别:
Identification and optimization of verapamil as a novel neuroprotective and anti-inflammatory agent for reducing long-term neurological morbidities following organophosphate-induced status epilepticus
维拉帕米作为新型神经保护和抗炎剂的鉴定和优化,用于减少有机磷引起的癫痫持续状态后的长期神经系统发病率
- 批准号:
10727765 - 财政年份:2023
- 资助金额:
$ 41.2万 - 项目类别:
Elucidation of anti-inflammatory mechanism of surface layer protein of lactic acid bacteria focusing on its interaction with lipopolysaccharide.
阐明乳酸菌表面层蛋白的抗炎机制,重点关注其与脂多糖的相互作用。
- 批准号:
23K13905 - 财政年份:2023
- 资助金额:
$ 41.2万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Anti-inflammatory Effects of Hydrogen Gas Produced by Gut Microflora in a Mouse Model of ARDS
肠道菌群产生的氢气对 ARDS 小鼠模型的抗炎作用
- 批准号:
23K08467 - 财政年份:2023
- 资助金额:
$ 41.2万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Knockdown of AdipoR2 Compromises Adiponectin’s Anti-inflammatory Actions by Mainly Promoting a Pro-inflammatory Chemokine and Cytokine Secretory Profile in THP-1 Macrophages
AdipoR2 的敲低主要通过促进 THP-1 巨噬细胞中促炎趋化因子和细胞因子的分泌特征来损害脂联素的抗炎作用
- 批准号:
493138 - 财政年份:2023
- 资助金额:
$ 41.2万 - 项目类别:
SBIR Phase I: Structure-guided design of anti-inflammatory modulators of protease-activated receptor 1 (PAR1)
SBIR I 期:蛋白酶激活受体 1 (PAR1) 抗炎调节剂的结构引导设计
- 批准号:
2223225 - 财政年份:2023
- 资助金额:
$ 41.2万 - 项目类别:
Standard Grant
Targeting anti-viral and anti-inflammatory responses during ocular HSV-1 infection to prevent vision impairment.
针对眼部 HSV-1 感染期间的抗病毒和抗炎反应,以预防视力障碍。
- 批准号:
10651054 - 财政年份:2023
- 资助金额:
$ 41.2万 - 项目类别: